Regulation of Cardiac Hypertrophic Signaling by Prolyl Isomerase Pin1

DOI Web Site PubMed 被引用文献10件 参考文献49件 オープンアクセス
  • Haruhiro Toko
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Mathias H. Konstandin
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Shirin Doroudgar
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Lucia Ormachea
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Eri Joyo
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Anya Y. Joyo
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Shabana Din
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Natalie A. Gude
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Brett Collins
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Mirko Völkers
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Donna J. Thuerauf
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Christopher C. Glembotski
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Chun-Hau Chen
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Kun Ping Lu
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Oliver J. Müller
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Takafumi Uchida
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...
  • Mark A. Sussman
    From the Department of Biology, San Diego State University Heart Institute, San Diego State University, San Diego, CA (H.T., M.H.K., S.D., L.O., E.J., A.Y.J., S.D., N.A.G., B.C., M.V., D.J.T., C.C.G., M.A.S.); Department of Medicine, Center for Life Science, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (C-H.C., K.P.L.); Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany (O.J.M.); and Molecular Enzymology, Department of Molecular Cell Science,...

この論文をさがす

説明

<jats:sec> <jats:title> <jats:underline>Rationale:</jats:underline> </jats:title> <jats:p>Cardiac hypertrophy results from the complex interplay of differentially regulated cascades based on the phosphorylation status of involved signaling molecules. Although numerous critical regulatory kinases and phosphatases have been identified in the myocardium, the intracellular mechanism for temporal regulation of signaling duration and intensity remains obscure. In the nonmyocyte context, control of folding, activity, and stability of proteins is mediated by the prolyl isomerase Pin1, but the role of Pin1 in the heart is unknown.</jats:p> </jats:sec> <jats:sec> <jats:title> <jats:underline>Objective:</jats:underline> </jats:title> <jats:p>To establish the role of Pin1 in the heart.</jats:p> </jats:sec> <jats:sec> <jats:title> <jats:underline>Methods and Results:</jats:underline> </jats:title> <jats:p>Here, we show that either genetic deletion or cardiac overexpression of Pin1 blunts hypertrophic responses induced by transaortic constriction and consequent cardiac failure in vivo. Mechanistically, we find that Pin1 directly binds to Akt, mitogen activated protein kinase (MEK), and Raf-1 in cultured cardiomyocytes after hypertrophic stimulation. Furthermore, loss of Pin1 leads to diminished hypertrophic signaling of Akt and MEK, whereas overexpression of Pin1 increases Raf-1 phosphorylation on the autoinhibitory site Ser259, leading to reduced MEK activation.</jats:p> </jats:sec> <jats:sec> <jats:title> <jats:underline>Conclusions:</jats:underline> </jats:title> <jats:p>Collectively, these data support a role for Pin1 as a central modulator of the intensity and duration of 2 major hypertrophic signaling pathways, thereby providing a novel target for regulation and control of cardiac hypertrophy.</jats:p> </jats:sec>

収録刊行物

  • Circulation Research

    Circulation Research 112 (9), 1244-1252, 2013-04-26

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (10)*注記

もっと見る

参考文献 (49)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ